Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial

William Whang, Matthew M. Burg, Robert M. Carney, Kenneth E. Freedland, J. Thomas Bigger, Diane Catellier, Susan Czajkowski, Nancy Frasure-Smith, Donald C. Haas, Allan S Jaffe, Francois Lespérance, Vivian Medina, Joan Duer-Hefele, Gabrielle A. Osorio, Faith Parsons, Peter A. Shapiro, David S. Sheps, Viola Vaccarino, Karina W. Davidson

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference-based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.

Original languageEnglish (US)
Pages (from-to)1003-1010
Number of pages8
JournalContemporary Clinical Trials
Volume33
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Patient Preference
Acute Coronary Syndrome
Randomized Controlled Trials
Depression
Phase III Clinical Trials
Random Allocation
Telephone
Psychotherapy
Primary Health Care
Therapeutics

Keywords

  • Acute coronary syndrome
  • Clinical trial
  • Depression

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Medicine(all)

Cite this

Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. / Whang, William; Burg, Matthew M.; Carney, Robert M.; Freedland, Kenneth E.; Bigger, J. Thomas; Catellier, Diane; Czajkowski, Susan; Frasure-Smith, Nancy; Haas, Donald C.; Jaffe, Allan S; Lespérance, Francois; Medina, Vivian; Duer-Hefele, Joan; Osorio, Gabrielle A.; Parsons, Faith; Shapiro, Peter A.; Sheps, David S.; Vaccarino, Viola; Davidson, Karina W.

In: Contemporary Clinical Trials, Vol. 33, No. 5, 09.2012, p. 1003-1010.

Research output: Contribution to journalArticle

Whang, W, Burg, MM, Carney, RM, Freedland, KE, Bigger, JT, Catellier, D, Czajkowski, S, Frasure-Smith, N, Haas, DC, Jaffe, AS, Lespérance, F, Medina, V, Duer-Hefele, J, Osorio, GA, Parsons, F, Shapiro, PA, Sheps, DS, Vaccarino, V & Davidson, KW 2012, 'Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial', Contemporary Clinical Trials, vol. 33, no. 5, pp. 1003-1010. https://doi.org/10.1016/j.cct.2012.05.005
Whang, William ; Burg, Matthew M. ; Carney, Robert M. ; Freedland, Kenneth E. ; Bigger, J. Thomas ; Catellier, Diane ; Czajkowski, Susan ; Frasure-Smith, Nancy ; Haas, Donald C. ; Jaffe, Allan S ; Lespérance, Francois ; Medina, Vivian ; Duer-Hefele, Joan ; Osorio, Gabrielle A. ; Parsons, Faith ; Shapiro, Peter A. ; Sheps, David S. ; Vaccarino, Viola ; Davidson, Karina W. / Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial. In: Contemporary Clinical Trials. 2012 ; Vol. 33, No. 5. pp. 1003-1010.
@article{393c0a9a888f447ab46c821c9df9c8a2,
title = "Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial",
abstract = "This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference-based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.",
keywords = "Acute coronary syndrome, Clinical trial, Depression",
author = "William Whang and Burg, {Matthew M.} and Carney, {Robert M.} and Freedland, {Kenneth E.} and Bigger, {J. Thomas} and Diane Catellier and Susan Czajkowski and Nancy Frasure-Smith and Haas, {Donald C.} and Jaffe, {Allan S} and Francois Lesp{\'e}rance and Vivian Medina and Joan Duer-Hefele and Osorio, {Gabrielle A.} and Faith Parsons and Shapiro, {Peter A.} and Sheps, {David S.} and Viola Vaccarino and Davidson, {Karina W.}",
year = "2012",
month = "9",
doi = "10.1016/j.cct.2012.05.005",
language = "English (US)",
volume = "33",
pages = "1003--1010",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Design and baseline data from the vanguard of the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS) randomized controlled trial

AU - Whang, William

AU - Burg, Matthew M.

AU - Carney, Robert M.

AU - Freedland, Kenneth E.

AU - Bigger, J. Thomas

AU - Catellier, Diane

AU - Czajkowski, Susan

AU - Frasure-Smith, Nancy

AU - Haas, Donald C.

AU - Jaffe, Allan S

AU - Lespérance, Francois

AU - Medina, Vivian

AU - Duer-Hefele, Joan

AU - Osorio, Gabrielle A.

AU - Parsons, Faith

AU - Shapiro, Peter A.

AU - Sheps, David S.

AU - Vaccarino, Viola

AU - Davidson, Karina W.

PY - 2012/9

Y1 - 2012/9

N2 - This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference-based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.

AB - This paper describes the rationale and design of the vanguard for the Comparison of Depression Interventions after Acute Coronary Syndrome (CODIACS), a multicenter, randomized, controlled trial of a patient preference-based, stepped care protocol for persistent depressive symptoms after acute coronary syndrome (ACS). The overall aim of the vanguard phase was to determine whether the patient-preference, stepped care protocol, which is based on the intervention used in the recent Coronary Psychosocial Evaluation Studies (COPES) trial, was feasible in patients with recent ACS who were recruited from 5 geographically diverse sites. Innovative design features of this trial include randomization to either initial patient-preference of treatment or to a referred care arm in which the primary care provider decided upon care. Additionally, delivery of psychotherapy was accomplished by telephone, or webcam, depending upon patient preference. The vanguard phase provides estimates of eligibility and screening/enrollment ratios, patient acceptance of screening, and retention. In this report, we describe the innovative features and the baseline results of the vanguard phase of CODIACS. The data from this vanguard study will be used to finalize planning for a large, phase III clinical trial designed to evaluate the effect of treatment on depressive symptoms, coronary events, and death.

KW - Acute coronary syndrome

KW - Clinical trial

KW - Depression

UR - http://www.scopus.com/inward/record.url?scp=84864296261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864296261&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2012.05.005

DO - 10.1016/j.cct.2012.05.005

M3 - Article

C2 - 22640924

AN - SCOPUS:84864296261

VL - 33

SP - 1003

EP - 1010

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

IS - 5

ER -